Higher plasma vitamin D levels associated with lower biomarkers of cardiometabolic disease.
The United States Centers for Disease Control and Prevention (CDC) reports a reduction in risk factors for cardiometabolic disease among men and women with higher plasma vitamin D levels. *
Canadian researchers evaluated data from 1,928 men and women between the ages of 6 and 79 years who participated in the Canadian Health Measures Survey. Blood samples obtained during physical examinations were analyzed for glucose, fasting insulin, C-reactive protein, fibrinogen, homocysteine, triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1, apolipoprotein B, and 25-hydroxyvitamin D [25(OH)D].
Vitamin D levels varied according to the month during which plasma levels were sampled. Subjects who had higher levels of vitamin D had reductions in insulin, insulin resistance, triglycerides, total cholesterol, LDL cholesterol, and ratio of total to HDL cholesterol.
Editor's Note: Cardiometabolic disease, also known as metabolic syndrome, is characterized by dyslipidemia, dysglycemia, abdominal obesity, and hypertension, which greatly increase the risk of cardiovascular disease and diabetes.
* Prev Chronic Dis. 2013 Jun 6;10:E91.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||IN THE NEWS|
|Article Type:||Brief article|
|Date:||Sep 1, 2013|
|Previous Article:||Research supports causative role for reduced vitamin D levels in high blood pressure.|
|Next Article:||Cinnamon compounds may protect against tau protein aggregation in Alzheimer's Disease.|